Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 14, 2026 02:00 ET | Source: PannTheraPi

PannTheraPi annonce des avancées majeures dans son développement clinique et stratégique

PannTheraPi annonce des avancées majeures dans son développement clinique et stratégique Le dépôt du dossier réglementaire pour l’initiation de l’essai clinique de Phase 2a évaluant son candidat...
April 14, 2026 02:00 ET | Source: PannTheraPi

PannTheraPi Announces Significant Clinical Development and Strategic Milestones

PannTheraPi files Phase 2a trial for epilepsy drug PTI5803, secures EU patent, and appoints Sophie Binay as GM & CSO.
April 13, 2026 10:29 ET | Source: Research and Markets

Small Molecule Innovator API CDMO Market Outlook, 2026-2033 - Lonza Group, Novo Holdings (Catalent) and Thermo Fisher Scientific Lead the Growing Industry

Dublin, April 13, 2026 (GLOBE NEWSWIRE) -- The "Small Molecule Innovator API CDMO Market Size, Share & Trends Analysis Report by Stage Type, Customer Type, Therapeutic Area, Region, and Segment...
April 13, 2026 08:00 ET | Source: Veld Pharmaceuticals GmBH

Veld Pharmaceuticals GmbH Announces Collaboration with Chiesi Farmaceutici S.p.A to Expand Access to Rare Disease Therapies Across Africa

Veld Pharmaceuticals, announced a collaboration with Chiesi Farmaceutici S.p.A in Africa for Rare Disease Therapies
April 09, 2026 07:00 ET | Source: Soleo Health Holdings, Inc.

Soleo Health Opens New Ambulatory Infusion Center in Austin, Texas

FRISCO, Texas and AUSTIN, Texas, April 09, 2026 (GLOBE NEWSWIRE) -- Soleo Health, an innovative leader and national provider of complex specialty pharmacy services, announced today the opening of...
April 06, 2026 07:00 ET | Source: Agios Pharmaceuticals, Inc.

Agios to Host First Quarter 2026 Financial Results Conference Call and Webcast on April 29 at 8:00 a.m. ET

Agios will report its first quarter 2026 financial results and business highlights on Wednesday, April 29, 2026.
April 01, 2026 07:04 ET | Source: Foundation for Sarcoidosis Research

A Kaleidoscope Inspires the Foundation for Sarcoidosis “See Sarcoidosis” Global Campaign for Sarcoidosis Awareness Month

Foundation for Sarcoidosis Research Launches See Sarcoidosis Campaign for April's Awareness Month
April 01, 2026 07:00 ET | Source: Soleo Health Holdings, Inc.

Soleo Health Selected as an Authorized Specialty Pharmacy of QIVIGY® For Primary Humoral Immunodeficiency (PI) Treatment

FRISCO, Texas, April 01, 2026 (GLOBE NEWSWIRE) -- Soleo Health, an innovative leader and national provider of complex specialty pharmacy services, announced today it has been named a limited...
March 31, 2026 07:00 ET | Source: Agios Pharmaceuticals, Inc.

Agios Advances Mitapivat Toward Potential U.S. Accelerated Approval in Sickle Cell Disease Following Pre-sNDA Meeting with FDA

Agios announces it will pursue U.S. accelerated approval for mitapivat in sickle cell disease
March 30, 2026 07:30 ET | Source: Biogen Inc.

FDA Approves New High Dose Regimen of SPINRAZA® (nusinersen) for Spinal Muscular Atrophy

The approval was anchored on data from the pivotal DEVOTE study that investigated the efficacy and safety of the High Dose Regimen of SPINRAZA in treatment-naïve and previously treated SPINRAZA...